Drugs Made In America Acquisition (DMAA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.87, +0.00% vs the prior close of $10.87.
- Volume 794 shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DMAA ends flat (+0.0%) to $10.87. Closed at $10.87, +0.00% vs the prior close of $10.87. Day range $10.87–$10.87, opened at $10.87.
DMAA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DMAA ends flat (+0.0%) to $10.87
- Closed at $10.87, +0.00% vs the prior close of $10.87. Day range $10.87–$10.87, opened at $10.87.
- Volume was 794 shares, 0.0x its 50-day average of 22.56K — lighter than usual.
- Price is +0.6% vs its 50-day average ($10.80) and +2.5% vs its 200-day average ($10.61).
- 52-week range $10.29–$10.89; today's close sits at 97% of that range, 0.2% below the 52-week high.
Oct 15, 2026 — DMAA ends flat (+0.1%) to $10.87
- Closed at $10.87, +0.09% vs the prior close of $10.86. Day range $10.85–$10.87, opened at $10.85.
- Volume was 7.40K shares, 0.3x its 50-day average of 22.41K — lighter than usual.
- Price is +0.7% vs its 50-day average ($10.80) and +2.5% vs its 200-day average ($10.60).
- 52-week range $10.29–$10.89; today's close sits at 97% of that range, 0.2% below the 52-week high.
Oct 14, 2026 — DMAA ends flat (+0.0%) to $10.86
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
- Price is +0.6% vs its 50-day average ($10.80) and +2.4% vs its 200-day average ($10.60).
- 52-week range $10.28–$10.89; today's close sits at 95% of that range, 0.3% below the 52-week high.
Oct 13, 2026 — DMAA ends flat (+0.0%) to $10.86
- Closed at $10.86, +0.00% vs the prior close of $10.86. Day range $10.86–$10.86, opened at $10.86.
- Price is +0.6% vs its 50-day average ($10.79) and +2.5% vs its 200-day average ($10.60).
- 52-week range $10.28–$10.89; today's close sits at 95% of that range, 0.3% below the 52-week high.
Oct 12, 2026 — DMAA ends flat (+0.1%) to $10.86 on 2.6x normal volume
- Closed at $10.86, +0.09% vs the prior close of $10.85. Day range $10.85–$10.86, opened at $10.85.
- Volume was 55.20K shares, 2.6x its 50-day average of 21.47K — unusually heavy trading.
- Price is +0.6% vs its 50-day average ($10.79) and +2.5% vs its 200-day average ($10.60).
- 52-week range $10.26–$10.89; today's close sits at 95% of that range, 0.3% below the 52-week high.
Oct 9, 2026 — DMAA ends flat (+0.0%) to $10.85
- Closed at $10.85, +0.00% vs the prior close of $10.85. Day range $10.85–$10.85, opened at $10.85.
- Volume was 13.50K shares, 0.6x its 50-day average of 21.20K.
- Price is +0.6% vs its 50-day average ($10.79) and +2.4% vs its 200-day average ($10.59).
- 52-week range $10.26–$10.89; today's close sits at 94% of that range, 0.4% below the 52-week high.
Oct 8, 2026 — DMAA ends flat (+0.1%) to $10.85
- Closed at $10.85, +0.09% vs the prior close of $10.84. Day range $10.85–$10.85, opened at $10.85.
- Volume was 5.40K shares, 0.3x its 50-day average of 21.29K — lighter than usual.
- Price is +0.6% vs its 50-day average ($10.78) and +2.4% vs its 200-day average ($10.59).
- 52-week range $10.26–$10.89; today's close sits at 94% of that range, 0.4% below the 52-week high.
Oct 7, 2026 — DMAA dips 0.5% to $10.84 on 1.9x normal volume
- Closed at $10.84, -0.46% vs the prior close of $10.89. Day range $10.82–$10.85, opened at $10.85.
- Volume was 38.90K shares, 1.9x its 50-day average of 20.71K — unusually heavy trading.
- Price is +0.5% vs its 50-day average ($10.78) and +2.4% vs its 200-day average ($10.59).
- 52-week range $10.26–$10.89; today's close sits at 92% of that range, 0.5% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — DMAA ends flat (+0.0%) to $10.89, 3 down days in a row
- Closed at $10.89, +0.00% vs the prior close of $10.89. Day range $10.82–$10.89, opened at $10.82.
- Volume was 500 shares, 0.0x its 50-day average of 20.70K — lighter than usual.
- Price is +1.0% vs its 50-day average ($10.78) and +2.9% vs its 200-day average ($10.59).
- 52-week range $10.26–$10.89; today's close sits at 100% of that range, at a new 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — DMAA ends flat (+0.0%) to $10.89
- Closed at $10.89, +0.00% vs the prior close of $10.89. Day range $10.89–$10.89, opened at $10.89.
- Price is +1.1% vs its 50-day average ($10.77) and +2.9% vs its 200-day average ($10.59).
- 52-week range $10.26–$10.89; today's close sits at 100% of that range, at a new 52-week high.
Oct 2, 2026 — DMAA ends flat (+0.0%) to $10.89
- Closed at $10.89, +0.00% vs the prior close of $10.89. Day range $10.89–$10.89, opened at $10.89.
- Price is +1.1% vs its 50-day average ($10.77) and +2.9% vs its 200-day average ($10.58).
- 52-week range $10.26–$10.89; today's close sits at 100% of that range, at a new 52-week high.
DMAA latest news & SEC filings
Every SEC filing by or about DMAA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $1.73M (prior year $2.29M) (-24.5% vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jun 26, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DMAA
- How much it moves: over the last 20 sessions the average daily move was 0.07% (largest 0.5%). That is a relatively calm stock.
- Liquidity: about 6.44K shares (≈$70.05K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.87 vs a range of $10.29–$10.89 (97% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 14, 2026; 8-K Jul 20, 2026.
- Share count: 24.28M shares outstanding (Aug 14, 2026), -27.6% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Blank Checks.
DMAA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.87 | 10.87 | 10.87 | 10.87 | 794 |
| Oct 15, 2026 | 10.85 | 10.87 | 10.85 | 10.87 | 7.40K |
| Oct 14, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 0 |
| Oct 13, 2026 | 10.86 | 10.86 | 10.86 | 10.86 | 0 |
| Oct 12, 2026 | 10.85 | 10.86 | 10.85 | 10.86 | 55.20K |
| Oct 9, 2026 | 10.85 | 10.85 | 10.85 | 10.85 | 13.50K |
| Oct 8, 2026 | 10.85 | 10.85 | 10.85 | 10.85 | 5.40K |
| Oct 7, 2026 | 10.85 | 10.85 | 10.82 | 10.84 | 38.90K |
| Oct 6, 2026 | 10.82 | 10.89 | 10.82 | 10.89 | 500 |
| Oct 5, 2026 | 10.89 | 10.89 | 10.89 | 10.89 | 0 |
| Oct 2, 2026 | 10.89 | 10.89 | 10.89 | 10.89 | 0 |
| Oct 1, 2026 | 10.89 | 10.89 | 10.89 | 10.89 | 900 |
| Sep 30, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 0 |
| Sep 29, 2026 | 10.84 | 10.88 | 10.84 | 10.88 | 800 |
| Sep 28, 2026 | 10.88 | 10.88 | 10.88 | 10.88 | 300 |
| Sep 25, 2026 | 10.82 | 10.84 | 10.82 | 10.84 | 1.50K |
| Sep 24, 2026 | 10.85 | 10.85 | 10.85 | 10.85 | 200 |
| Sep 23, 2026 | 10.85 | 10.85 | 10.85 | 10.85 | 200 |
| Sep 22, 2026 | 10.82 | 10.85 | 10.82 | 10.85 | 700 |
| Sep 21, 2026 | 10.85 | 10.85 | 10.84 | 10.85 | 2.60K |
About Drugs Made In America Acquisition
Drugs Made In America Acquisition (DMAA) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 2028614.
DMAA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
DMAA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $5.94M | — | $-539.19K |
Latest balance sheet: total assets $146.90M, total liabilities $9.14M, cash $20.28K (as of Jun 30, 2026).
DMAA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DMAA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.